L Horn

Activity and tolerability of afatinib (BIBW 2992) and cetuximab in NSCLC patients with acquired resistance to erlotinib or gefitinib.

H. Groen, W. Pao, E. Smit, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

My Cancer Genome: Web-based clinical decision support for genome-directed lung cancer treatment.

L Horn, W Pao, M A Levy, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

M. Ahn, E. Felip, K. Emancipator, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.